Tumor necrosis factor-α and receptor activator of nuclear factor-κB ligand augment human macrophage foam-cell destruction of extracellular matrix through protease-mediated processes

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Tumor necrosis factor-α and receptor activator of nuclear factor-κB ligand augment human macrophage foam-cell destruction of extracellular matrix through protease-mediated processes. / Skjøt-Arkil, Helene; Barascuk, Natasha; Larsen, Lise; Dziegiel, Morten Hanefeld; Henriksen, Kim; Karsdal, Morten A.

In: ASSAY and Drug Development Technologies, Vol. 10, No. 1, 02.2012, p. 69-77.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Skjøt-Arkil, H, Barascuk, N, Larsen, L, Dziegiel, MH, Henriksen, K & Karsdal, MA 2012, 'Tumor necrosis factor-α and receptor activator of nuclear factor-κB ligand augment human macrophage foam-cell destruction of extracellular matrix through protease-mediated processes', ASSAY and Drug Development Technologies, vol. 10, no. 1, pp. 69-77. https://doi.org/10.1089/adt.2010.0366

APA

Skjøt-Arkil, H., Barascuk, N., Larsen, L., Dziegiel, M. H., Henriksen, K., & Karsdal, M. A. (2012). Tumor necrosis factor-α and receptor activator of nuclear factor-κB ligand augment human macrophage foam-cell destruction of extracellular matrix through protease-mediated processes. ASSAY and Drug Development Technologies, 10(1), 69-77. https://doi.org/10.1089/adt.2010.0366

Vancouver

Skjøt-Arkil H, Barascuk N, Larsen L, Dziegiel MH, Henriksen K, Karsdal MA. Tumor necrosis factor-α and receptor activator of nuclear factor-κB ligand augment human macrophage foam-cell destruction of extracellular matrix through protease-mediated processes. ASSAY and Drug Development Technologies. 2012 Feb;10(1):69-77. https://doi.org/10.1089/adt.2010.0366

Author

Skjøt-Arkil, Helene ; Barascuk, Natasha ; Larsen, Lise ; Dziegiel, Morten Hanefeld ; Henriksen, Kim ; Karsdal, Morten A. / Tumor necrosis factor-α and receptor activator of nuclear factor-κB ligand augment human macrophage foam-cell destruction of extracellular matrix through protease-mediated processes. In: ASSAY and Drug Development Technologies. 2012 ; Vol. 10, No. 1. pp. 69-77.

Bibtex

@article{9bab7bd025d84f9b8ced12674a772e18,
title = "Tumor necrosis factor-α and receptor activator of nuclear factor-κB ligand augment human macrophage foam-cell destruction of extracellular matrix through protease-mediated processes",
abstract = "By secreting proteases such as cathepsins and matrix metalloproteinases (MMPs), macrophage foam cells may be a major cause of ruptured atherosclerotic plaques. The aims of the present study were to investigate in vitro role of human macrophage foam cells in degrading type I collagen, a major component of extracellular matrix (ECM) in plaques, and to establish whether the pro-inflammatory molecules, tumor necrosis factor (TNF)-alpha, and receptor activator of nuclear factor-κB ligand (RANK-L) increase this degradation. CD14+ monocytes isolated from peripheral blood were differentiated into macrophage foam cells and cultured on a type I collagen matrix in the presence of TNF-alpha and RANK-L. Matrix degradation was measured by the cathepsin K-generated C-terminal cross-linked telopeptide of type I collagen (CTX-I) and the MMP-generated carboxyterminal telopeptide of type I collagen (ICTP) in supernatants showing that macrophage foam cells secrete MMPs and cathepsin K, resulting in release of ICTP and CTX-I. Stimulation with TNF-alpha increased CTX-I and ICTP dose dependently, with ICTP levels increasing by 59% and CTX-I levels increasing by 43%. RANK-L enhanced the release of CTX-I and ICTP by 56% and 72%, respectively. This is, to our knowledge, the first data describing a simple in vitro system in which macrophage foam cells degradation of matrix proteins can be monitored. This degradation can be enhanced by cytokines since TNF-alpha and RANK-L significantly increased the matrix degradation. This in vitro system in part is a model system for the macrophage-mediated proteolytic degradation of the ECM, which is found in many diseases with an inflammatory component.",
keywords = "Atherosclerosis, Biological Markers, Cathepsin K, Cells, Cultured, Collagen Type I, Extracellular Matrix, Foam Cells, Humans, Inflammation Mediators, Matrix Metalloproteinase 2, Matrix Metalloproteinase 9, Peptides, RANK Ligand, Tumor Necrosis Factor-alpha, Up-Regulation",
author = "Helene Skj{\o}t-Arkil and Natasha Barascuk and Lise Larsen and Dziegiel, {Morten Hanefeld} and Kim Henriksen and Karsdal, {Morten A}",
year = "2012",
month = feb,
doi = "10.1089/adt.2010.0366",
language = "English",
volume = "10",
pages = "69--77",
journal = "Assay and Drug Development Technologies",
issn = "1540-658X",
publisher = "Mary AnnLiebert, Inc. Publishers",
number = "1",

}

RIS

TY - JOUR

T1 - Tumor necrosis factor-α and receptor activator of nuclear factor-κB ligand augment human macrophage foam-cell destruction of extracellular matrix through protease-mediated processes

AU - Skjøt-Arkil, Helene

AU - Barascuk, Natasha

AU - Larsen, Lise

AU - Dziegiel, Morten Hanefeld

AU - Henriksen, Kim

AU - Karsdal, Morten A

PY - 2012/2

Y1 - 2012/2

N2 - By secreting proteases such as cathepsins and matrix metalloproteinases (MMPs), macrophage foam cells may be a major cause of ruptured atherosclerotic plaques. The aims of the present study were to investigate in vitro role of human macrophage foam cells in degrading type I collagen, a major component of extracellular matrix (ECM) in plaques, and to establish whether the pro-inflammatory molecules, tumor necrosis factor (TNF)-alpha, and receptor activator of nuclear factor-κB ligand (RANK-L) increase this degradation. CD14+ monocytes isolated from peripheral blood were differentiated into macrophage foam cells and cultured on a type I collagen matrix in the presence of TNF-alpha and RANK-L. Matrix degradation was measured by the cathepsin K-generated C-terminal cross-linked telopeptide of type I collagen (CTX-I) and the MMP-generated carboxyterminal telopeptide of type I collagen (ICTP) in supernatants showing that macrophage foam cells secrete MMPs and cathepsin K, resulting in release of ICTP and CTX-I. Stimulation with TNF-alpha increased CTX-I and ICTP dose dependently, with ICTP levels increasing by 59% and CTX-I levels increasing by 43%. RANK-L enhanced the release of CTX-I and ICTP by 56% and 72%, respectively. This is, to our knowledge, the first data describing a simple in vitro system in which macrophage foam cells degradation of matrix proteins can be monitored. This degradation can be enhanced by cytokines since TNF-alpha and RANK-L significantly increased the matrix degradation. This in vitro system in part is a model system for the macrophage-mediated proteolytic degradation of the ECM, which is found in many diseases with an inflammatory component.

AB - By secreting proteases such as cathepsins and matrix metalloproteinases (MMPs), macrophage foam cells may be a major cause of ruptured atherosclerotic plaques. The aims of the present study were to investigate in vitro role of human macrophage foam cells in degrading type I collagen, a major component of extracellular matrix (ECM) in plaques, and to establish whether the pro-inflammatory molecules, tumor necrosis factor (TNF)-alpha, and receptor activator of nuclear factor-κB ligand (RANK-L) increase this degradation. CD14+ monocytes isolated from peripheral blood were differentiated into macrophage foam cells and cultured on a type I collagen matrix in the presence of TNF-alpha and RANK-L. Matrix degradation was measured by the cathepsin K-generated C-terminal cross-linked telopeptide of type I collagen (CTX-I) and the MMP-generated carboxyterminal telopeptide of type I collagen (ICTP) in supernatants showing that macrophage foam cells secrete MMPs and cathepsin K, resulting in release of ICTP and CTX-I. Stimulation with TNF-alpha increased CTX-I and ICTP dose dependently, with ICTP levels increasing by 59% and CTX-I levels increasing by 43%. RANK-L enhanced the release of CTX-I and ICTP by 56% and 72%, respectively. This is, to our knowledge, the first data describing a simple in vitro system in which macrophage foam cells degradation of matrix proteins can be monitored. This degradation can be enhanced by cytokines since TNF-alpha and RANK-L significantly increased the matrix degradation. This in vitro system in part is a model system for the macrophage-mediated proteolytic degradation of the ECM, which is found in many diseases with an inflammatory component.

KW - Atherosclerosis

KW - Biological Markers

KW - Cathepsin K

KW - Cells, Cultured

KW - Collagen Type I

KW - Extracellular Matrix

KW - Foam Cells

KW - Humans

KW - Inflammation Mediators

KW - Matrix Metalloproteinase 2

KW - Matrix Metalloproteinase 9

KW - Peptides

KW - RANK Ligand

KW - Tumor Necrosis Factor-alpha

KW - Up-Regulation

U2 - 10.1089/adt.2010.0366

DO - 10.1089/adt.2010.0366

M3 - Journal article

C2 - 22053710

VL - 10

SP - 69

EP - 77

JO - Assay and Drug Development Technologies

JF - Assay and Drug Development Technologies

SN - 1540-658X

IS - 1

ER -

ID: 47555607